Your browser doesn't support javascript.
loading
Concomitant Medications for Progressive Supranuclear Palsy: A Secondary Analysis of a Randomized Clinical Trial.
Iyer, Jay M; Gunzler, Douglas; Lang, Anthony E; Golbe, Lawrence I; Pantelyat, Alexander; Boxer, Adam L; Wills, Anne-Marie.
Afiliação
  • Iyer JM; Departments of Molecular and Cellular Biology and Statistics, Harvard University, Cambridge, Massachusetts.
  • Gunzler D; Population Health Research Institute, Center for Health Care Research and Policy, MetroHealth Medical Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio.
  • Lang AE; Edmond J. Safra Program in Parkinson's Disease, Rossy Progressive Supranuclear Palsy Centre, Movement Disorders Clinic, Krembil Brain Institute, Toronto Western Hospital, University Health Network and Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
  • Golbe LI; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
  • Pantelyat A; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Boxer AL; Memory and Aging Center, Department of Neurology, University of California, San Francisco.
  • Wills AM; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
JAMA Neurol ; 81(3): 295-297, 2024 Mar 01.
Article em En | MEDLINE | ID: mdl-38252447
This secondary analysis of a randomized clinical trial examines changes in the progression of progressive supranuclear palsy (PSP) associated with 31 concomitant medication classes used by study participants over 1 year.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Paralisia Supranuclear Progressiva Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: JAMA Neurol Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Paralisia Supranuclear Progressiva Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: JAMA Neurol Ano de publicação: 2024 Tipo de documento: Article